Variations of alpha 2-plasmin inhibitor, antithrombin III, plasminogen in the serum of patients of cerebral thrombosis infused with urokinase.
D000818:Animals; D000990:Antithrombin III; D010450:Endopeptidases / Q000627:therapeutic use*; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D005779:Immunodiffusion; D007123:Immunoelectrophoresis, Two-Dimensional; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy*; D010958:Plasminogen; D011817:Rabbits; D013997:Time Factors; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*; D000979:alpha-2-Antiplasmin
D000979:alpha-2-Antiplasmin; D000990:Antithrombin III; D010958:Plasminogen; D010450:Endopeptidases; D014568:Urokinase-Type Plasminogen Activator